Live Breaking News & Updates on John Menditto

Stay updated with breaking news from John menditto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events

BASKING RIDGE, N.J., May 28, 2024 Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other. ....

United States , San Diego , Elizabeth Coleman , John Menditto , Davidj Mazzo , International Convention , Lisata Therapeutics Inc , Corporate Communications , Chief Executive Officer , Investor Relations ,

Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer

Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed Significant clinical trial burden and costs avoided due to waiver BASKING RIDGE, N.J., May 20, 2024 . ....

Elizabeth Coleman , John Menditto , Corporate Communications , Lisata Therapeutics Inc , European Medicines Agency , European Union , Exchange Commission , Paediatric Committee , Paediatric Investigation Plan , Executive Vice President , Chief Medical Officer , Paediatric Regulation , Fast Track , Orphan Drug Designation , Rare Pediatric Disease Designation , Private Securities Litigation Reform Act , Nasdaq Capital Market , Annual Report , Investor Relations ,

Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines ...

Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed ....

Elizabeth Coleman , John Menditto , European Medicines Agency , Paediatric Committee , Lisata Therapeutics Inc , European Union , Exchange Commission , Corporate Communications , Paediatric Investigation Plan , Executive Vice President , Chief Medical Officer , Paediatric Regulation , Fast Track , Orphan Drug Designation , Rare Pediatric Disease Designation , Cendr Platform , Private Securities Litigation Reform Act , Nasdaq Capital Market , Annual Report , Investor Relations ,

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , New South Wales , New Zealand , John Menditto , Robert Leboyer , Pete Enderlin , Erkki Ruoslahti , David Mazzo , James Nisco , Robert Sassoon , Joseph Pantginis , Steve Brozak , Sara Nik , Therapeutic Goods Administration , Clinical Trial Center , Therapeutic Goods Regulatory Agency Of The Australian , Water Tower Research , Exchange Commission , University Of Sydney , Data Safety Monitoring Committee , Intestinal Cancer Trials Group , European Union , Corporate Communications , International Nonproprietary Name , Cendr Platform Technology , Lisata Therapeutics Inc ,

Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events

Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , John Menditto , Tariq Imam , Davidj Mazzo , Business Development Licensing , Business Development , Oncology Innovation Forum , Lisata Therapeutics Inc , Corporate Communications , Upcoming May , Partnering Conference , Chief Executive Officer , Annual Oncology Innovation Forum , Investor Relations ,